## Pentose Phosphate Pathway — Tissue Distribution **Key Point:** The pentose phosphate pathway (PPP) is most active in tissues with high biosynthetic and reductive demands, particularly the liver and adipose tissue. ### Why Liver and Adipose Tissue? Both tissues are major sites of: 1. **Lipogenesis** — fatty acid and cholesterol synthesis require NADPH as a reducing agent 2. **Nucleotide synthesis** — ribose-5-phosphate production for DNA/RNA synthesis 3. **Antioxidant defense** — NADPH regeneration for glutathione reduction systems The liver accounts for approximately **30% of total body PPP activity**, while adipose tissue is the second most active site due to continuous triglyceride synthesis. ### Comparative Tissue Activity | Tissue | PPP Activity | Reason | |--------|--------------|--------| | **Liver** | Very High | Lipogenesis, cholesterol synthesis, detoxification | | **Adipose Tissue** | Very High | Fatty acid synthesis, energy storage | | **Skeletal Muscle** | Low | Primarily oxidative phosphorylation | | **Heart** | Low | Minimal biosynthetic demand | | **RBCs** | Moderate | Antioxidant defense (no mitochondria) | | **Kidney Medulla** | Low | Limited biosynthetic activity | **High-Yield:** RBCs have a unique dependence on PPP for NADPH to maintain reduced glutathione (GSH), which protects against oxidative stress — but absolute activity is lower than liver/adipose. ### Clinical Pearl Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency present with hemolytic anemia upon oxidative stress (fava beans, sulfonamides) because RBCs cannot generate sufficient NADPH via the PPP to maintain antioxidant defenses. This highlights the critical role of PPP in RBC metabolism, though overall tissue activity remains lower than in liver/adipose. **Mnemonic:** **LANK** — Liver and Adipose are the major sites; Nucleotide synthesis and NADPH for biosynthesis drive the pathway.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.